The price of Epclusa (sofosbuvir/velpatasvir tablets) varies depending on the region, purchase channel, and medical insurance policy. In China, the price per box typically ranges from several thousand to over ten thousand yuan, depending on the actual purchase channel. This is a prescription drug and must be used strictly according to a doctor's prescription.
Price Influencing Factors
Epclusa is an antiviral drug for hepatitis C. Its price in China is affected by factors such as the dosage (e.g., 28 tablets/box), whether it is covered by medical insurance, and the procurement policies of hospitals or pharmacies. In some regions, the out-of-pocket portion may be reduced by more than 50% after medical insurance reimbursement.
Prices vary significantly when purchased overseas or through agents; caution should be exercised regarding the legality and quality risks of the drug's source.
Medical Insurance and Reimbursement Policies
Epclusa is included in the National Medical Insurance Catalog (2023 edition), but the reimbursement rate varies depending on regional policies. Some provinces classify it as a special outpatient disease drug, requiring a doctor's prescription and diagnosis certificate for reimbursement.
Low-income or particularly disadvantaged groups can consult their local medical insurance department; some cities offer additional subsidies.
Medication and Medical Guidance
The course of treatment for Epclusa (hepatitis C virus) needs to be determined based on the patient's hepatitis C virus genotype and liver function status. It is usually one tablet taken orally daily for 12 weeks. Do not adjust the dosage or stop taking the medication on your own. Regular monitoring of viral load and liver function is necessary.
Mild side effects such as headache and fatigue may occur during medication. If symptoms persist or worsen, seek medical attention promptly.
Purchase Precautions
Purchase only from regular hospitals or qualified pharmacies. Avoid obtaining medication through irregular channels to prevent the risk of counterfeit drugs.
Before taking the medication, determine if there are any drug interactions (caution is needed when using it in combination with antiepileptic drugs or anti-tuberculosis drugs), and inform the doctor of your past medical history and medication history.
It is recommended that hepatitis C patients prioritize consultation with the infectious disease department or hepatology specialist of a public hospital. A doctor will assess the condition and prescribe medication. Simultaneously, familiarize yourself with the local medical insurance reimbursement process to reduce treatment costs.
